[Cite as http://purl.org/au-research/grants/nhmrc/545931]
Prof Gail Risbridger
Brief description Prostate cancer is hormonally regulated and currently managed by androgen ablation. This application seeks to study the potential benefits of estrogen action for the treatment of prostate disease, including PCa. We will show estrogen hormone action causes prostatic cell death, targeting the stem-progenitor cells so the treated prostatic tissue does not regenerate. This project will provide pre-clinical proof of the efficacy of estrogenic compounds as a potential therapy for prostate disease.
Funding Amount $AUD 594,722.14
Funding Scheme NHMRC Project Grants
Standard Project Grant